Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/15/2012EP2486008A1 Inorganic salt complexes of vildagliptin
08/15/2012EP2486007A1 P-glycoprotein-specific non-competitive peptide and peptidomimetic modulators
08/15/2012EP2486006A1 Sulfonamido pyrrolidine compounds which inhibit beta-secretase activity and methods of use thereof
08/15/2012EP2486005A1 Pyrrolidine gpr40 modulators
08/15/2012EP2486004A2 Sulphone compounds and methods of making and using same
08/15/2012EP2485752A2 Enterotoxigenic e. coli fusion protein vaccines
08/15/2012EP2485747A1 Dna-directed customization of analgesic compounds as a therapeutic modality
08/15/2012EP2485746A2 Cytoprotective or therapeutic plant composition
08/15/2012EP2485742A1 Antibiotic formulations providing reduced gastrointentestinal side effects
08/15/2012EP2485740A1 Methods for preventing or treating sarcopenia and muscle atrophy in animals
08/15/2012EP2485739A1 Methods and compositions for maintenance of a functional wound
08/15/2012EP2485738A2 Compositions and methods for treating obesity
08/15/2012EP2485737A1 Novel trpa1 antagonists
08/15/2012EP2485736A1 Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
08/15/2012EP2485735A1 Inhibitors of fatty acid binding protein (fabp)
08/15/2012EP2485734A1 Diuretics
08/15/2012EP2485733A2 Methods for treating alzheimer's disease
08/15/2012EP2485731A1 Heterocyclic compounds useful as pdk1 inhibitors
08/15/2012EP2485730A1 Topical formulation comprising etoricoxib and a zwitterionic surfactant
08/15/2012EP2485729A1 Treatment with cholinergic agonists
08/15/2012EP2485727A2 Pyrrolopyrazoles for treating cns disorders
08/15/2012EP2485726A1 Fluoro-substituted 3,5-dicyano-4-(1h-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof
08/15/2012EP2485725A2 Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof
08/15/2012EP2485724A1 Sulfonamides for the prevention of diabetes
08/15/2012EP2485723A1 Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets
08/15/2012EP2485722A1 Use of rasagiline for the treatment of progressive supranuclear palsy
08/15/2012EP2485721A2 Apogossypolone derivatives as anticancer agents
08/15/2012EP2485717A1 Delivery system for sustained release of a calcium -channel blocking agent
08/15/2012EP2485716A2 Pharmaceutical composition comprising poorly soluble active ingredient and hyperbranched polymer
08/15/2012EP2485715A1 Pharmaceutical compositions comprising rivaroxaban
08/15/2012EP2485714A1 Novel pharmaceutical composition comprising a macrolide immunosuppressant drug
08/15/2012EP2485712A1 Subcutaneous paliperidone composition
08/15/2012EP2485710A1 Carrageenan-containing aqueous antimicrobial compositions
08/15/2012EP2485606A1 Amino acid composition with improved dispersibility
08/15/2012EP2485596A1 Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
08/15/2012EP2485595A1 Combination therapy using a beta 3 adrenergic receptor agonist and an antimuscarinic agent
08/15/2012EP2485594A1 Combination
08/15/2012EP2485593A1 Combination
08/15/2012EP2485591A1 Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
08/15/2012EP2485590A1 Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions, and their use
08/15/2012EP2485589A1 Heteroaryl btk inhibitors
08/15/2012EP2358710B1 Akt and p70 s6 kinase inhibitors
08/15/2012EP2344482B1 Benzo[d]isoxazol-3-yl-piperazin derivatives useful as modulators of dopamine d3 receptors
08/15/2012EP2324007B1 Triazole derivatives and their use as nicotinic acetylcholine receptor modulators
08/15/2012EP2299977B1 Liposomes for drug delivery and methods for preparation thereof
08/15/2012EP2297162B1 Compounds
08/15/2012EP2297159B1 Substituted quinazolines
08/15/2012EP2297128B1 Inhibitors of ikk- serine-threonine protein kinase
08/15/2012EP2285393B1 Compositions for the treatment of disorders of the upper respiratory tract and influenza syndromes
08/15/2012EP2276756B9 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
08/15/2012EP2271643B1 Oxadiazoles as s1p1 receptor agonists
08/15/2012EP2257546B1 Functionally selective alpha2c adrenoreceptor agonists
08/15/2012EP2238143B1 Nitric oxide donor compounds
08/15/2012EP2238127B1 Pyrazole-carboxamide derivatives as p2y12 antagonists
08/15/2012EP2231590B9 Antitumoral compounds
08/15/2012EP2229154B1 Pharmaceutical containing a hormone combination having a contraceptive effect and an insulin sensitizer
08/15/2012EP2212323B1 Imidazo [1,2-a] pyridine derivatives useful as alk inhibitors
08/15/2012EP2205268B1 Interferon alpha sequential regimen for treating cancers
08/15/2012EP2190837B1 4-pyrimidinesulfamide derivative
08/15/2012EP2188283B1 Annelated pyridazines for the treatment of tumors driven by inappropriate hedgehog signalling
08/15/2012EP2171448B1 Methods for inhibiting tumor growth by targeting the ssdna replication intermediate of tumor stem cells
08/15/2012EP2167469B1 Sulfonyl-quinoline derivatives
08/15/2012EP2153843B1 Compositions and methods for the diagnosis and treatment of tumor
08/15/2012EP2148658B1 Improved vitamin d content uniformity in pharmaceutical dosage forms
08/15/2012EP2146988B1 New 4,8-diphenyl-polyazanaphthalene derivatives
08/15/2012EP2142185B1 Droxidopa and pharmaceutical composition thereof for the treatment of neurally mediated hypotension
08/15/2012EP2139488B1 Use of riboflavin in the treatment of hypertension
08/15/2012EP2136631B1 Methods for treating neoplasia with combination of chemotherapeutic agents and radiation
08/15/2012EP2114875B1 Substituted arylcylopentenes as therapeutic agents
08/15/2012EP2114394B1 Platinum analogs with bis-nitrile-containing ligands
08/15/2012EP2102185B1 Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
08/15/2012EP2094714B1 Substituted thienopyridone compounds with antibacterial activity
08/15/2012EP2044004B1 Benzamide derivatives as modulators of 11beta-hsd1 for treating diabetes and obesity
08/15/2012EP2032128B1 Use of substituted 2-aminotetralines for the manufacture of a medicament for the prevention, alleviation and/or treatment of various types of pain
08/15/2012EP1991523B1 Selective androgen receptor modulators
08/15/2012EP1986632B1 Combinations comprising a cdk inhibitor and a growth factor antibody or anti-mitotic
08/15/2012EP1978944B1 Soft-gelatin capsule formulation
08/15/2012EP1976470B1 Laser energy calibration based on optical measurement
08/15/2012EP1975162B1 Oxazolone derivative
08/15/2012EP1965808B1 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, processes for the preparation thereof, and uses thereof
08/15/2012EP1960389B1 Compounds which have activity at m1 receptor and their uses in medicine
08/15/2012EP1951718B9 4-oxadiazolyl-piperidine compounds and use thereof
08/15/2012EP1931322B1 Ikk inhibitors for the treatment of endometriosis
08/15/2012EP1906912B1 Method for prolonging the life of animals
08/15/2012EP1898914B1 Quinoline derivatives as antibacterial agents
08/15/2012EP1896450B1 2-substituted benzimidazoles
08/15/2012EP1896077B1 Methods and compositions for the prevention and treatment of inflammatory disease
08/15/2012EP1894567B1 Concomitant pharmaceutical agents and use thereof
08/15/2012EP1893590B1 Benzooxazole-2-on derivatives as lipase and phospholipase inhibitors
08/15/2012EP1869060B1 Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof
08/15/2012EP1868569B8 Liquid aqueous dosage forms for sub-lingual or nasal applications of active agents with amino groups
08/15/2012EP1864666B1 Protective agent for retinal neuronal cell containing prostaglandin f2 alpha derivative as active ingredient
08/15/2012EP1791568B1 Therapeutic uses of inhibitors of rtp801
08/15/2012EP1773790B1 Benzyltriazolone compounds as non-nucleoside reverse transcriptase inhibitors
08/15/2012EP1741431B1 The combination for treating hyperlipemia
08/15/2012EP1727543B1 Use of 14,15-dihydro-20,21-dinoreburnamenin-14-ol for the treatment and/or prevention of serious depression
08/15/2012EP1656370B1 Biaryl heterocyclic compounds and methods of making and using the same
08/15/2012EP1642899B1 2,4-bis(trifluoroethoxy)pyridine compound and medicine containing the same
08/15/2012EP1641755B1 2-hydroxymethyl-3,4,5-trihydroxy-1-(4-pentlyoxybenzyl)piperidine as glucosylceramide synthase (gcs) inhibitor
08/15/2012EP1626963B1 Substituted pyrazoline compounds, their preparation and use as medicaments
1 ... 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 ... 7860